Deserpidine antagonism by a tripeptide, L-prolyl-L-leucyglycinamide.

Suppr

超能文献

作者信息

Plotnikoff N P, Kastin A J, Anderson M S, Schally A V

出版信息

Neuroendocrinology. 1973;11(1):67-71. doi: 10.1159/000122119.

DOI:10.1159/000122119

PMID:4633626

Abstract

摘要

相似文献

Deserpidine antagonism by a tripeptide, L-prolyl-L-leucyglycinamide.

Neuroendocrinology. 1973;11(1):67-71. doi: 10.1159/000122119.

Effect of deserpidine and pargyline on the levels of biogenic amines in brain, liver and heart of mice.去甲氧基萝芙木碱和帕吉林对小鼠脑、肝和心脏中生物胺水平的影响。

Res Commun Chem Pathol Pharmacol. 1972 Mar;3(2):245-8.

Oxotremorine antagonism by prolyl-leucyl-glycine-amide administered by different routes and with several anticholinergics.

Pharmacol Biochem Behav. 1974 May;2(3):417-9. doi: 10.1016/0091-3057(74)90090-2.

L-prolyl-L-leucyl-glycinamide (PLG): influences on locomotor and stereotyped behavior of cats.L-脯氨酰-L-亮氨酰-甘氨酰胺（PLG）：对猫的运动和刻板行为的影响。

Brain Res. 1973 Dec 7;63:435-9. doi: 10.1016/0006-8993(73)90119-4.

Hypothalamic releasing factors and Parkinson disease.

Arch Neurol. 1974 Jul;31(1):55-6. doi: 10.1001/archneur.1974.00490370081013.

[Clinical study of enduron-deserpidine].[恩杜隆-利血平的临床研究]

Lille Med. 1967 Feb;12(2):Suppl:120-2.

Study of the structural requirements for dopa potentiation and oxotremorine antagonism by L-prolyl-L-leucylglycinamide.L-脯氨酰-L-亮氨酰甘氨酰胺对多巴增效作用和氧化震颤素拮抗作用的结构要求研究。

J Med Chem. 1978 Feb;21(2):165-9. doi: 10.1021/jm00200a004.

The reserpine, rescinnamine, and deserpidine content of Rauwolfia roots.萝芙木根中利血平、利血胺和去甲利血平的含量。

J Am Pharm Assoc Am Pharm Assoc. 1958 Sep;47(9):625-7.

DOPA potentiation in ablated animals and brain levels of biogenic amines in intact animals after prolyl-leucylglycinamide.切除动物中的多巴增强作用以及脯氨酰 - 亮氨酰甘氨酰胺处理后完整动物体内生物胺的脑水平。

Neuroendocrinology. 1974;14(5):271-9. doi: 10.1159/000122270.

Neuropharmacological review of hypothalamic releasing factors.下丘脑释放因子的神经药理学综述

Adv Biochem Psychopharmacol. 1977;17:81-107.

引用本文的文献

Concepts for biologically active peptides.生物活性肽的概念。

Curr Pharm Des. 2010 Oct;16(30):3390-400. doi: 10.2174/138161210793563491.

Mass spectrometric quantification of MIF-1 in mouse brain by multiple reaction monitoring.通过多反应监测对小鼠脑中巨噬细胞迁移抑制因子-1进行质谱定量分析。

Peptides. 2009 Jul;30(7):1276-81. doi: 10.1016/j.peptides.2009.04.004. Epub 2009 Apr 11.

Effect of cyclo(Leu-Gly) on reserpine-induced hypomotility and increases in cortical beta-adrenergic receptors.环（亮氨酸-甘氨酸）对利血平诱导的运动功能减退及皮质β-肾上腺素能受体增加的影响。

Psychopharmacology (Berl). 1984;83(1):76-8. doi: 10.1007/BF00427426.

Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.左旋多巴与其他药物的相互作用：在帕金森病治疗中的意义

Drugs. 1973;6(5):364-88. doi: 10.2165/00003495-197306050-00004.

MSH-release inhibiting factors: recent studies.促黑激素释放抑制因子：近期研究

Yale J Biol Med. 1973 Dec;46(5):617-22.

Tremorogenic effect of thyrotropin releasing hormone in rats.促甲状腺激素释放激素对大鼠的致颤效应。

Experientia. 1974 Oct 15;30(10):1168-70. doi: 10.1007/BF01923670.

Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia.神经垂体激素、类似物及片段：它们对嘌呤霉素诱导失忆的影响。

Proc Natl Acad Sci U S A. 1975 Oct;72(10):4180-4. doi: 10.1073/pnas.72.10.4180.

Failure of MIF-I to affect behavioral responses in patients with Parkinson's diseases under L-dopa therapy.

Psychopharmacology (Berl). 1979 Jun 21;63(3):217-22. doi: 10.1007/BF00433553.

On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use.关于促白细胞移动抑制因子（Pro-Leu-Gly-NH2，MIF）在神经药理学试验及临床应用中的最佳剂量

Naunyn Schmiedebergs Arch Pharmacol. 1977 Jun;298(2):79-81. doi: 10.1007/BF00508614.

Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.帕金森病中口服L-脯氨酰-L-亮氨酰-甘氨酸酰胺的双盲评估

Can Med Assoc J. 1976 Jan 24;114(2):120-2.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验